BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28237785)

  • 1. Multisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection.
    López JI; Cortés JM
    Hum Pathol; 2017 Jun; 64():1-6. PubMed ID: 28237785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.
    Erramuzpe A; Cortés JM; López JI
    Virchows Arch; 2018 Feb; 472(2):187-194. PubMed ID: 28842744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma.
    Lopez JI; Cortes JM
    F1000Res; 2016; 5():385. PubMed ID: 27127618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Tumor Eco-Evolution in Renal Cell Carcinoma Sampling.
    López-Fernández E; López JI
    Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30518081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.
    Cortés JM; de Petris G; López JI
    Front Med (Lausanne); 2017; 4():25. PubMed ID: 28321395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive pathology in routine diagnostics of solid tumors.
    Lassmann S; Werner M
    Histol Histopathol; 2012 Mar; 27(3):289-96. PubMed ID: 22237706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-site tumor sampling (MSTS) improves the performance of histological detection of intratumor heterogeneity in clear cell renal cell carcinoma (CCRCC).
    Guarch R; Cortés JM; Lawrie CH; López JI
    F1000Res; 2016; 5():2020. PubMed ID: 27635226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist.
    López JI
    APMIS; 2016 Mar; 124(3):153-9. PubMed ID: 26865355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.
    McBride M; Rida PC; Aneja R
    Mol Aspects Med; 2015 Nov; 45():3-13. PubMed ID: 26024970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovering intratumor heterogeneity: the next frontier for pathologists.
    López JI; De Petris G
    Pathologica; 2017 Jun; 109(2):110-113. PubMed ID: 28748969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level.
    Manini C; López-Fernández E; Lawrie CH; Laruelle A; Angulo JC; López JI
    Curr Urol Rep; 2022 Jun; 23(6):93-97. PubMed ID: 35416538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Immunohistochemistry: Digital, Analytical and Integrated.
    Laurinavicius A; Plancoulaine B; Herlin P; Laurinaviciene A
    Pathobiology; 2016; 83(2-3):156-63. PubMed ID: 27101138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry 2015: Protein correlates of molecular alterations and predictive testing.
    Hornick JL
    Semin Diagn Pathol; 2015 Sep; 32(5):323-4. PubMed ID: 26250936
    [No Abstract]   [Full Text] [Related]  

  • 14. A multi-site cutting device implements efficiently the divide-and-conquer strategy in tumor sampling.
    Lopez JI; Cortes JM
    F1000Res; 2016; 5():1587. PubMed ID: 27540472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Heterogeneity in Breast Cancer.
    Badve S; Gökmen-Polar Y
    Adv Anat Pathol; 2015 Sep; 22(5):294-302. PubMed ID: 26262511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in the pathological diagnosis of lymphoma.
    Li X
    Chin Clin Oncol; 2015 Mar; 4(1):3. PubMed ID: 25841710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumor Heterogeneity in Breast Cancer.
    Beca F; Polyak K
    Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Heterogeneity: Will It Change What Pathologists Do.
    Bosman FT
    Pathobiology; 2018; 85(1-2):18-22. PubMed ID: 28482346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry as a Practical Tool in Molecular Pathology.
    Sheffield BS
    Arch Pathol Lab Med; 2016 Aug; 140(8):766-9. PubMed ID: 27472235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
    Besusparis J; Plancoulaine B; Rasmusson A; Augulis R; Green AR; Ellis IO; Laurinaviciene A; Herlin P; Laurinavicius A
    Diagn Pathol; 2016 Aug; 11(1):82. PubMed ID: 27576949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.